Novartis, Elan Sue IPC Over Generic Focalin XR
Novartis Pharma AG and Elan Corp. PLC slapped Intellipharmaceutics Corp. with patent infringement suits in New Jersey and Delaware on Friday over the company's efforts to market a generic version of...To view the full article, register now.
Already a subscriber? Click here to view full article